Frequently asked questions

cap-LITE-uh

CAPLYTA is a prescription medicine used to treat adults with schizophrenia.

Although the exact way CAPLYTA works is unknown, it is thought to affect different brain‑signaling chemicals to help control schizophrenia symptoms.

Weight change on CAPLYTA was similar to placebo in short-term trials. In a long-term study, patients on CAPLYTA for one year had an average weight loss of 7 pounds.

CAPLYTA, like other drugs used to treat schizophrenia, may cause problems with your metabolism, including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood, and weight gain. Your doctor should check your blood sugar, fat levels, and weight before you start and during your treatment with CAPLYTA. Extremely high blood sugar levels can lead to coma or death. Tell your doctor if you have symptoms of high blood sugar, which include feeling very thirsty, hungry, sick to your stomach, weak/tired, or needing to urinate more than usual. Each drug has its own specific risk profile.

The most common side effects with CAPLYTA are sleepiness (24%) and dry mouth (6%). In clinical trials, sleepiness was predominantly mild. Follow your healthcare provider's direction on when and how to take CAPLYTA. CAPLYTA can cause sleepiness and trouble concentrating. Until you know how CAPLYTA affects you, do not drive, operate heavy machinery, or do other dangerous activities.

CAPLYTA is a once-daily pill to be taken with or without food.

Your healthcare provider may tell you what time of day or night is best for you to take CAPLYTA. CAPLYTA can cause sleepiness and trouble concentrating. Until you know how CAPLYTA affects you, do not drive, operate heavy machinery, or do other dangerous activities.